Conclusion
Significant difference in PK parameters and bio-distribution of
nanoparticles in spleen and lymph nodes with maximum deposition were
observed in large intestine. Nanoparticle distribution pattern may be
advantageous for the treatment of intestinal or lymph node TB and has
the potential to result in a lower dose of rifampicin nanoformulation
for the treatment of pulmonary TB.